Exelixis Announces FDA Approval of CABOMETYX (cabozantinib) Tablets for Previously Treated Hepatocellular Carcinoma Read more
Key Pharmaceuticals Ltd to lead a workshop on Parallel Trade & Brexit during the 13th Annual Parallel Trade Conference Read more
Puma and Knight Enter into Exclusive License Agreement to Commercialize NERLYNX (neratinib) in Canada Read more
Chinese API Market Growing Strongly, CPhI China Assisting Enterprises with the Transformation, Innovation, and Comprehensive Upgrading Read more
bioLIVE China 2019 to be Newly Upgraded, to Lead the Development of the Bio-Pharma Technology in Asia Read more
SIRION and Denali Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System Read more
Clinigen Extends Exclusive European Clinical Trial Sourcing and Supply Agreement with Accord Healthcare Read more